The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers.
Invesco Pharmaceuticals ETF PJP
Morningstar’s Analysis PJP
Will PJP outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 56.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Geron Corp | 6.99 | 18.9 Mil | Healthcare |
Amgen Inc | 6.24 | 16.9 Mil | Healthcare |
Eli Lilly and Co | 5.91 | 16.0 Mil | Healthcare |
Pfizer Inc | 5.90 | 16.0 Mil | Healthcare |
Merck & Co Inc | 5.86 | 15.9 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 5.81 | 15.7 Mil | Healthcare |
Johnson & Johnson | 5.44 | 14.7 Mil | Healthcare |
AbbVie Inc | 5.26 | 14.2 Mil | Healthcare |
Abbott Laboratories | 5.18 | 14.0 Mil | Healthcare |
United Therapeutics Corp | 4.36 | 11.8 Mil | Healthcare |